About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Parkinson's Disease Clinical Trials | 122 Studies Recruiting

Clinical TrialsParkinson's Disease

Parkinson's Disease Clinical Trials

Browse 122 clinical trials for parkinson's disease. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 61-80 of 122 trials

RecruitingDyadic Mindfulness for People With Parkinson's Disease and Their CaregiversThe proposed two-arm randomized waitlist-controlled trial will use a mixed-methods design to investigate the effects of dyadic mindfulness on physio-psycho-spiritual outcomes in…NCT06821230·Hong Kong RecruitingNeurologic Stem Cell Treatment StudyThis is a human clinical study involving the isolation of autologous bone marrow derived stem cells (BMSC) and transfer to the vascular system and inferior 1/3 of the nasal…NCT02795052·Westport, Connecticut and 2 others

Related Searches

parkinsonstrials

Data from ClinicalTrials.govTerms

UnknownSpeech Intelligibility of Patients With P D Compared to First Degree Relatives of P D PatientsThis study will examine speech intelligibility of early parkinson's disease (PD) patients, early PD patients and first degree relatives.NCT01776879

Not yet recruitingGamification and Physical Activity in PDDespite overwhelming evidence that exercise can improve motor and non-motor symptoms of Parkinson's Disease (PD), less than 25% of Veterans with PD meet recommended activity goals.NCT07286994·Philadelphia, Pennsylvania

RecruitingA Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's DiseaseStudy BRT-DA01-301 is a Phase 3 multicenter, randomized, sham surgery-controlled, double-blind study to assess efficacy and safety of bemdaneprocel in approximately 102 adults…NCT06944522·Scottsdale, Arizona and 42 others

Not yet recruitingMetformin in Parkinson's Disease: Safety and EfficacyThis study will evaluate whether metformin when it will be given to patients with Parkinson's disease along with standard therapy (levodopa carbidopa) will improve motor symptoms…NCT07806019

RecruitingAutologous suraL nervE Grafting to the Substantia nigrA in Patients With SynuclienopathiesThis phase I double-blind study focuses on the safety and feasibility of implanting autologous peripheral nerve tissue (PNT) into the substantia nigra area of the brain in persons…NCT06683365·Lexington, Kentucky

WithdrawnEssential Amino Acids and Parkinsons DiseaseParkinson's disease is a neuromuscular disease that is relatively common in elderly that has many potentials symptoms, including a variety of physical features that together…NCT06604065

CompletedEfficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD PatientsThe objectives of this trial conducted in early Parkinson's Disease (PD) patients are to determine the efficacy (as measured by the change from baseline to the end of the…NCT00479401·Gilbert, Arizona and 94 others

RecruitingStudy to Investigate Vagus Nerve Stimulation to Augment Executive Function in Healthy and Cognitively Impaired PopulationsThis study plans to learn more about how stimulating the vagus nerve through gentle electrical stimulation applied to the ear can affect decision-making, problem-solving, and…NCT07424365·Aurora, Colorado

UnknownBETA Study: Improving Balance Function in Elderly by Progressive and Specific Training and Physical ActivityBalance control, physical activity and health related quality of life will be assessed before and after a 10 to 12 weeks training program as well as 6 and 12 months thereafter in…NCT01417598·Stockholm, Huddinge

CompletedCognitive Exercise Therapy Approach (BETY) in Parkinson's DiseaseConsidering the impact of motor and non-motor findings on movement problems in the disease management of people living with PD, biopsychosocial evaluation and treatment approaches…NCT06893120·Antalya, Alanya and 1 other

TerminatedDoes N-Acetylcysteine Decrease Spontaneous Oxidation of Central Neural Dopamine in Parkinson's Disease?Background: Parkinsons disease (PD) causes slow movement, stiffness, and poor balance. Many symptoms are due to the loss of brain cells that make the brain chemical dopamine.NCT03104725·Bethesda, Maryland

CompletedProspective Evaluation of Forceplate Measured Levodopa-Induced DyskinesiaNearly all Parkinson's disease (PD) patients eventually develop abnormal and unwanted movements (dyskinesias; LID) caused by the gold standard treatment, Levodopa.NCT00912977·Portland, Oregon

CompletedTherapeutic Potential for Intranasal Levodopa in Parkinson's Disease -Off ReversalA Phase IIa, Randomized, Double Blind, Placebo Controlled, Single Dose, Safety and Pharmacokinetic/Pharmacodynamic Study of INP103 (POD L-dopa) Administered in the Presence of…NCT03541356·Sydney, New South Wales and 4 others

RecruitingUdall Project 1 Aim 4By defining the strength and direction of connectivity patterns at rest and during movement across the basal ganglia-thalamocortical (BGTC) network we will characterize the role…NCT05568199·Minneapolis, Minnesota

RecruitingMK-0947 PN-002: An Open-label Study to Evaluate Brain α-synuclein Deposition Using Positron Emission Tomography (PET) and [¹⁸F]MK-0947 in Participants With Parkinson's Disease (PD)This is a single-center, open-label clinical study designed to evaluate alpha-synuclein (ASYN) deposition in the brain of participants with Parkinson's disease (PD), as compared…NCT07880379·New Haven, Connecticut

RecruitingRevision of Deep Brain Stimulator in Patients With Parkinson's DiseaseParkinson's disease is a chronic and progressive neurodegenerative disease that affects the central nervous system, particularly impairing movement control.NCT07176494·Ankara, Yenimahalle\Ankara

RecruitingD-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease ProgressionThis clinical study, designed as a randomized, double-blind, placebo-controlled trial, aims to investigate if modulation of the N-methyl-D-aspartate receptor (NMDAR) via its…NCT07312110·Arendal, Agder and 10 others

CompletedProfile of Depressive Symptoms in Parkinsons DiseaseTo explore or establish the relationship between cognitive, mood and motor symptoms in PD to scores on depression rating scales in a naturalistic setting.NCT00349310·Innsbruck and 23 others

PreviousPage 4 of 7Next